ATI RN
Immune System Drugs Questions
Question 1 of 5
Which of the following patients would be eligible to receive the influenza vaccine?
Correct Answer: B
Rationale: The correct answer is B, the patient who is pregnant. Pregnant individuals are at higher risk of complications from influenza and are recommended to receive the influenza vaccine to protect themselves and their unborn child. A: The patient taking care of her son with HIV should also receive the influenza vaccine to prevent transmission, but this alone does not make her eligible for the vaccine. C: Patients with egg allergy can receive the influenza vaccine with appropriate precautions, so this does not automatically disqualify them. D: The child who is 18 months old is eligible for the influenza vaccine, but pregnant individuals are at higher risk, hence B is the correct answer.
Question 2 of 5
The nurse has an order to administer oprelvekin (Neumega) to a patient for the first time. Before administering the drug, what allergy would the nurse want to specifically question the patient about?
Correct Answer: B
Rationale: The correct answer is B: Escherichia coli-produced products. Oprelvekin is produced using genetically modified E. coli bacteria. The nurse should question the patient about any allergies to E. coli-produced products to prevent an allergic reaction. Choices A, C, and D are incorrect because oprelvekin is not derived from egg products, lactose, or penicillin.
Question 3 of 5
A patient who is receiving an immune suppressant has been admitted to the unit. What would be a priority action by the nurse?
Correct Answer: C
Rationale: The correct answer is C: Protect the patient from exposure to infection. This is the priority action because immune suppressants weaken the immune system, making the patient more susceptible to infections. By protecting the patient from exposure to infection, the nurse can prevent potential complications and promote the patient's safety. Monitoring nutritional status (A) is important but not as critical as preventing infections. Patient teaching (B) and providing support for adverse effects (D) can be addressed after ensuring the patient's safety from infections.
Question 4 of 5
A 70-year-old patient with acute myelocytic leukemia is receiving sargramostim (Leukine). What is a priority nursing action for this patient?
Correct Answer: B
Rationale: The correct answer is B: Increasing fluids. In a patient with acute myelocytic leukemia receiving sargramostim, hydration is crucial to prevent dehydration and maintain renal function due to the potential for increased urine output. Adequate fluids help prevent complications such as renal impairment and electrolyte imbalances. Providing a quiet environment (A) can be beneficial but not the priority. Comfort measures for nausea (C) are important but do not address the immediate need for hydration. Encouraging appropriate dietary intake (D) is important but not as critical as ensuring adequate fluid intake in this scenario.
Question 5 of 5
How do immune suppressants work when ordered for a patient who has had an organ transplant?
Correct Answer: A
Rationale: The correct answer is A: Blocking normal effects of the immune system. Immune suppressants are prescribed post-organ transplant to prevent rejection by inhibiting the immune system's response against the new organ. By blocking the immune system's normal function, these medications help maintain the transplanted organ's viability. Explanation for incorrect choices: B: Stimulating the immune system to fight off infection contradicts the purpose of immune suppressants, which aim to dampen the immune response. C: Working with corticosteroids to enhance healing is not the primary mechanism of action of immune suppressants. D: Working with corticosteroids to promote suppressor cells is not accurate as immune suppressants primarily target different pathways compared to corticosteroids.